Results 1 to 10 of about 70,002 (313)

Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?

open access: yesAnnals of Translational Medicine, 2020
Dermatomyositis is an autoimmune disease that occurs in association with underlying malignancy in a subset of patients. Given this association, diagnosis of dermatomyositis typically triggers malignancy screening.
Urmi Khanna   +3 more
semanticscholar   +1 more source

Association of Ultraviolet Radiation Exposure With Dermatomyositis in a National Myositis Patient Registry

open access: yesArthritis care & research, 2020
Dermatomyositis (DM) has been associated with geospatial differences in ultraviolet (UV) radiation, but the role of individual determinants of UV exposure prior to diagnosis is unknown.
C. Parks   +11 more
semanticscholar   +1 more source

JAK Inhibitors as Potential Therapeutic Strategy for the Dilemma of Psoriasis Concurrent with Dermatomyositis in the SARS-CoV-2 Era

open access: yesClinical, Cosmetic and Investigational Dermatology, 2023
Qiannan Xu, Nan Xu Department of Dermatology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence: Nan Xu, Tel +86 38804518, Email xnhrb@sina.comAbstract: Dermatomyositis is a rare inflammatory
Xu Q, Xu N
doaj  

Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis

open access: yesClinics, 2012
OBJECTIVE: To analyze major histocompatibility complex expression in the muscle fibers of juvenile and adult dermatomyositis. METHOD: In total, 28 untreated adult dermatomyositis patients, 28 juvenile dermatomyositis patients (Bohan and Peter's criteria)
Samuel Katsuyuki Shinjo   +3 more
doaj   +1 more source

Galectin‐9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation

open access: yesArthritis & Rheumatology, 2019
Objective evaluation of disease activity is challenging in patients with juvenile dermatomyositis (DM) due to a lack of reliable biomarkers, but it is crucial to avoid both under‐ and overtreatment of patients.
J. Wienke   +30 more
semanticscholar   +1 more source

Juvenile Dermatomyositis

open access: yesJournal of Rheumatic Diseases, 2022
Juvenile dermatomyositis (JDM) is a systemic capillary vasculopathy. Patients present with proximal muscle weakness, raised muscle enzymes, and pathognomic skin rashes such as heliotrope rash, Gottron's papules. Main complications are calcinosis, lipodystrophy, osteoporosis. Complement-mediated damage of vessels is a major mechanism. Magnetic resonance
openaire   +3 more sources

Ground-glass opacity heralding invasive lung adenocarcinoma with prodromal dermatomyositis: a case report

open access: yesJournal of Cardiothoracic Surgery, 2018
Background Dermatomyositis, an inflammatory myopathy with cutaneous involvement, is associated with malignancy and often manifests paraneoplastically. While co-occurrence with small cell carcinoma is well attested, primary lung adenocarcinoma, which may ...
Andrew J. Beel   +4 more
doaj   +1 more source

229 Comparative immune profiling of four autoimmune skin diseases identifies a mixed type-I and type-II interferon response as a unique inflammatory signature in skin dermatomyositis [PDF]

open access: bronze, 2023
K. Afshari   +11 more
openalex   +1 more source

Atypical presentation of anti-small ubiquitin-like modifier 1 and melanoma differentiation-associated gene 5 antibody positive dermatomyositis presenting with significant inflammatory myopathy on biopsy and normal creatine kinase levels: A case report

open access: yesSAGE Open Medical Case Reports
Idiopathic inflammatory myopathies are characterized by chronic inflammation of skeletal muscle. The main subtypes of idiopathic inflammatory myopathies include dermatomyositis, polymyositis, and necrotizing autoimmune myopathies.
Srikar Sama   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy